MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,765.36
-0.47%
NASDAQ 100
$30,725.81
-1.39%
DOW JONES
$51,232.00
+0.10%
NASDAQ Composite
$27,193.34
-1.25%
RUSSELL 2000
$2,775.70
-0.05%
CBOE VIX
$15.41
+2.19%
Sector Heatmap
Technology-1.79%
Financials+0.89%
Healthcare-0.39%
Consumer Cycl+0.31%
Consumer Staples+2.11%
Energy+2.97%
Industrials+0.33%
Materials+0.59%
Real Estate+0.69%
Utilities-0.19%
Comm Services+0.73%
SGP — SpyGlass Pharma, Inc. Common Stock
NasdaqSpyGlass Pharma, Inc. Common Stock
$24.62
+0.72(+3.01%)
- O
- 23.56
- H
- 24.84
- L
- 23.29
- V
- 64.63K
⏱️ End-of-day dataAs of Oct 8, 2026
Chart
About SGP
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateFeb 6, 2026
Employees65
Stock ExchangeNasdaq
Ticker SymbolSGP
Key Financial Statistics
| Market Cap | $833.52M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $17.06 - $32.44 |
| 52-Week Avg Volume | 116.0K |
| VWAP | $24.28 |
| Transactions | 2,981 |
| Total Recorded Bars | 169 days |